|
Index of reports
> Cases with Disease Progression ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Thalomid (Thalidomide) where reactions include disease progression. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Thalomid side effects in female
Reported by a physician from United States on 2012-07-25
Patient: female, weighing 65.4 kg (143.8 pounds)
Reactions: Drug Ineffective, Disease Progression
Drug(s) suspected as cause:
Thalomid
Other drugs received by patient: Lasix; Decadron
Possible Thalomid side effects in
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-07-16
Patient:
Reactions: Graft Versus Host Disease, Pulmonary Embolism, Toxicity To Various Agents, Polyneuropathy, Disease Progression, Death, Embolism Venous, Deep Vein Thrombosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalomid
Dosage: induction therapy, 200 mg escalated to 400 mg, qd, with vte prophylaxis
Administration route: Oral
Indication: Multiple Myeloma
Melphalan Hydrochloride
Dosage: 200 milligram/sq. meter
Cyclophosphamide
Dosage: 1000 milligram/sq. meter
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Adriamycin PFS
Dosage: 15 milligram/sq. meter
Thalomid
Dosage: maintenance therapy, 50 mg qd, without vte prophylaxis
Administration route: Oral
Adriamycin PFS
Dosage: 9 milligram/sq. meter
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Other drugs received by patient: Neupogen; Mycophenolate Mophetil; Cyclosporine; Nadroparine
Possible Thalomid side effects in female
Reported by a physician from United States on 2012-07-11
Patient: female, weighing 65.4 kg (143.8 pounds)
Reactions: Drug Ineffective, Adverse Event, Disease Progression
Drug(s) suspected as cause:
Thalomid
Other drugs received by patient: Lasix; Decadron
Possible Thalomid side effects in female
Reported by a physician from United States on 2012-07-05
Patient: female, weighing 65.4 kg (143.8 pounds)
Reactions: Drug Ineffective, Adverse Event, Disease Progression
Drug(s) suspected as cause:
Thalomid
Other drugs received by patient: Decadron; Lasix
Possible Thalomid side effects in
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-05-08
Patient:
Reactions: Neuropathy Peripheral, Pneumonia, Diabetes Mellitus, Sepsis, Anaemia, Neutropenia, Thrombocytopenia, Disease Progression, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Indication: Multiple Myeloma
Thalomid
Dosage: 100 milligram
Administration route: Oral
Indication: Multiple Myeloma
Bortezomib
Indication: Multiple Myeloma
Bortezomib
Vincristine
Indication: Multiple Myeloma
Adriamycin PFS
Indication: Multiple Myeloma
Other drugs received by patient: Aspirin; Neupogen; Melphalan Hydrochloride
Possible Thalomid side effects in
Reported by a physician from United States on 2012-04-02
Patient:
Reactions: Gastrointestinal Toxicity, Disease Progression, Haematotoxicity, Death, Hepatobiliary Disease, Metabolic Disorder, Electrolyte Imbalance, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalomid
Dosage: 50 milligram
Administration route: Oral
Thalomid
Dosage: 50 milligram
Administration route: Oral
Dexamethasone
Dosage: 12 milligram
Melphalan Hydrochloride
Dosage: 5 milligram/sq. meter
Cyclophosphamide
Dosage: 75 microgram/sq. meter
Thalomid
Dosage: 100 milligram
Administration route: Oral
Melphalan Hydrochloride
Dosage: 10 milligram/sq. meter
Indication: Multiple Myeloma
Melphalan Hydrochloride
Dosage: 20 milligram/sq. meter
Doxorubicin HCL
Dosage: 10 microgram/sq. meter
Cyclophosphamide
Dosage: 75 microgram/sq. meter
Bortezomib
Dosage: 1 milligram/sq. meter
Indication: Multiple Myeloma
Bortezomib
Dosage: 1 milligram/sq. meter
Bortezomib
Dosage: 1.3 milligram/sq. meter
Bortezomib
Dosage: 1.3 milligram/sq. meter
Dexamethasone
Dosage: 20 milligram
Dexamethasone
Dosage: 40 milligram
Melphalan Hydrochloride
Dosage: 4 milligram/sq. meter
Cisplatin
Dosage: 75 microgram/sq. meter
Doxorubicin HCL
Dosage: 10 microgram/sq. meter
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: 75 microgram/sq. meter
Revlimid
Dosage: 25 milligram
Administration route: Oral
Thalomid
Dosage: 100 milligram
Administration route: Oral
Dexamethasone
Dosage: 20 milligram
Melphalan Hydrochloride
Dosage: 5 milligram/sq. meter
Cisplatin
Dosage: 10 microgram/sq. meter
Indication: Multiple Myeloma
Cyclophosphamide
Dosage: 100 microgram/sq. meter
Etoposide
Dosage: 60 microgram/sq. meter
Revlimid
Dosage: 15 milligram
Administration route: Oral
Bortezomib
Dosage: 1 milligram/sq. meter
Dexamethasone
Dosage: 20 milligram
Cisplatin
Dosage: 75 microgram/sq. meter
Cyclophosphamide
Dosage: 100 microgram/sq. meter
Etoposide
Dosage: 80 microgram/sq. meter
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Thalomid
Dosage: 50 milligram
Administration route: Oral
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40 milligram
Dexamethasone
Dosage: 20 milligram
Cisplatin
Dosage: 10 microgram/sq. meter
Cisplatin
Dosage: 10 microgram/sq. meter
Doxorubicin HCL
Dosage: 75 microgram/sq. meter
Cyclophosphamide
Dosage: 400 microgram/sq. meter
Indication: Multiple Myeloma
Etoposide
Dosage: 40 microgram/sq. meter
Indication: Multiple Myeloma
Thalomid
Dosage: 200 milligram
Administration route: Oral
Indication: Multiple Myeloma
Thalomid
Dosage: 50 milligram
Administration route: Oral
Dexamethasone
Dosage: 20 milligram
Melphalan Hydrochloride
Dosage: 20 milligram/sq. meter
Etoposide
Dosage: 80 microgram/sq. meter
Thalomid
Dosage: 50 milligram
Administration route: Oral
Bortezomib
Dosage: 1.3 milligram/sq. meter
Dexamethasone
Dosage: 20 milligram
Dexamethasone
Dosage: 20 milligram
Doxorubicin HCL
Dosage: 10 microgram/sq. meter
Etoposide
Dosage: 60 microgram/sq. meter
Possible Thalomid side effects in 54 year old male
Reported by a physician from United States on 2012-03-23
Patient: 54 year old male
Reactions: Disease Progression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Thalomid
Indication: Product Used FOR Unknown Indication
Revlimid
Dosage: 15 mg, 1 in 1 d, po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-10-01
Other drugs received by patient: Cisplatin; Etoposide; Dexamethasone; Cyclophosphamide; Adriamycin PFS
Possible Thalomid side effects in
Reported by a individual with unspecified qualification from United States on 2012-03-13
Patient:
Reactions: Pneumonia Aspiration, Hyperglycaemia, Anaemia, Muscular Weakness, Rash, Constipation, Hypercalcaemia, Disease Progression, Fatigue, Neuropathy Peripheral, Oedema Peripheral, Neutropenia, Thrombocytopenia, Asthenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalomid
Dosage: 200 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-11-01
End date: 2011-01-01
Revlimid
Dosage: 50 milligram
Administration route: Oral
End date: 2011-01-01
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-11-01
Other drugs received by patient: Dexamethasone; Aspirin; Bisphosphonates; Neupogen; Blood Product Support; Warfarin Sodium; Heparin
|
